Kamada Ltd. Insider Trading
KMDA
Insiders sold $1.65M and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director David Tsur sold $1.46M on Sep 9, 29% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.
Get an email when KMDA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 14 | David Tsur Director | SoldNo plan | 22,827 | $8.18 | 187K | 5.3% | Form 4 |
| Sep 7 – 9 | David Tsur Director | SoldNo plan 3 parts | 177,173 | $8.26 average | $1.46M | 29% | Form 4 |
- Sep 14No planDavid TsurDirector · sold 22,827 at $8.18187K5.3% of stake
- Sep 7 – 9No planDavid TsurDirector · sold 177,173 at avg $8.26$1.46M29% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Drug Manufacturers - Specialty & Generic · Pick stocks to compare with KMDA
Held by ETFs
KMDA is in 3 US ETFs. The largest of them, with KMDA's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing KMDA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.